Study of StimRouter for Chronic Knee OA Pain
NCT05644639 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 13
Last updated 2024-06-26
Summary
The goal of this study is to evaluate the use of StimRouter Neuromodulation System (StimRouter) in adult subjects with an established diagnosis of primary femorotibial osteoarthritis in the target knee (Kellgren-Lawrence ≥1) who have surgical contraindications to undergo a knee joint arthroplasty procedure. The main questions it aims to answer are:
1. To assess the effect of the StimRouter Neuromodulation System to manage joint pain in patients with symptomatic OA of the knee who are surgically contraindicated to undergo a knee joint arthroplasty
2. To assess the effect of StimRouter on joint stiffness, function and patient quality of life
Participants will have StimRouter leads implanted then clinic visits will be scheduled for follow-up at Week 2, Month 3 and Month 6 (End of Study (EOS) or Early Termination (ET)).
Conditions
- Osteoarthritis, Knee
Interventions
- DEVICE
-
StimRouter Neuromodulation System
The StimRouter device is indicated for pain management in adults who have severe, intractable chronic pain of peripheral nerve origin and as an adjunct to other modes of therapy (e.g., medications). The StimRouter device is not intended to treat pain of craniofacial nerve origin.
Sponsors & Collaborators
-
Bioventus LLC
lead INDUSTRY
Principal Investigators
-
Stephen Mendelson, MD · Mendelson Kornblum Orthopedics
Eligibility
- Min Age
- 21 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-10-18
- Primary Completion
- 2023-10-01
- Completion
- 2024-06-21
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Regenerative Injection Therapy and Osteoarthritis
NCT01206634 ·Status: COMPLETED ·Phase: PHASE4
-
Geniculate Artery Embolization for Knee Osteoarthritis
NCT03835988 ·Status: WITHDRAWN ·Phase: NA
-
Pilot Synovial Fluid Molecular/Stem Cell Response to PRP in Knee Osteoarthritis: Clinical & Imaging Outcome Correlation
NCT02468492 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Genicular Artery Embolization for Reducing Pain in Medically Refractory Symptomatic Knee Osteoarthritis
NCT06859164 ·Status: RECRUITING ·Phase: PHASE2
-
Safety & Effectiveness of Autologous Regenerative Cell Therapy on Pain & Inflammation of Osteoarthritis of the Knee
NCT02844751 ·Status: RECRUITING ·Phase: PHASE2
-
Treatment of Knee Osteoarthritis by Intra-articular Injection of Bone Marrow Mesenchymal Stem Cells
NCT02123368 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Adipose-Derived Biocellular Regenerative Therapy for Osteoarthritis
NCT04238143 ·Status: RECRUITING ·Phase: NA
-
Registry of Celution Device for the Processing of Adipose Derived Regenerative Cells (ADRCs) to Treat Osteoarthritis
NCT02736110 ·Status: WITHDRAWN
-
Treatment of Osteoarthritis by Intra-articular Injection of Bone Marrow Mesenchymal Stem Cells With Platelet Rich Plasma
NCT02365142 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Autologous Adipose-derived Stromal Vascular Fraction for Treatment of Knee Osteoarthritis
NCT04440189 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Cartilage Recovery in Adults With Knee Osteorthritis by Mesenchymal Cell Therapy: Randomized Trial of Radiologic and Clinical Outcomes
NCT05936060 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
"Blind" vs. Fluoroscopy-Guided Steroid Injections for Knee Osteoarthritis
NCT02104726 ·Status: WITHDRAWN ·Phase: NA
-
An Investigation of ReNu™ Knee Injection in Patients With Osteoarthritis
NCT02318511 ·Status: COMPLETED ·Phase: NA
-
Geniculate Artery Embolization for Knee Osteoarthritis
NCT04951479 ·Status: COMPLETED ·Phase: NA
-
Bayer OA Knee Pain Pilot
NCT05349682 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
A Clinical Registry of Orthobiologics Procedures
NCT03011398 ·Status: ENROLLING_BY_INVITATION
-
Safety & Effectiveness of Autologous Regenerative Cell Therapy on Pain & Inflammation of Osteoarthritis of the Hip
NCT02844764 ·Status: RECRUITING ·Phase: PHASE2
-
Intra-articular Injection in the Knee of Adipose Derived Stromal Cells and Platelet Rich Plasma for Osteoarthritis
NCT03089762 ·Status: COMPLETED ·Phase: PHASE1
-
A Study Evaluating the Efficacy of a Single Injection Autologous Adipose Derived Mesenchymal Stromal Cells in Patients With Knee Osteoarthritis
NCT02838069 ·Status: COMPLETED ·Phase: PHASE2
-
HF10 Treatment of Chronic Knee Pain
NCT04020211 ·Status: TERMINATED
-
"Ready-to-use" Intra-articular Formulation of Mesenchymal Stromal Cells
NCT05751564 ·Status: UNKNOWN ·Phase: PHASE2
-
Safety Study of PTP-001 for Treating Knee Osteoarthritis
NCT04632966 ·Status: UNKNOWN ·Phase: PHASE1
-
Knee Osteoarthritis With Stromal Vascular Fraction Cells
NCT07259993 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
PRP Treatment of Osteoarthritic Knee With a New Autologous Blood Product (CytoRich)
NCT03543800 ·Status: UNKNOWN ·Phase: NA
-
Use of Autologous Adipose-Derived Stromal Vascular Fraction To Treat Osteoarthritis of Hip, Knee, Ankle, and Thumb Joints
NCT03166410 ·Status: UNKNOWN ·Phase: NA